Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
21.08. | Medicure GAAP EPS of -$0.08, revenue of $6.7M | 1 | Seeking Alpha | ||
21.08. | Medicure steigert Umsatz und verringert Verlust im Q2 2025 | 1 | Investing.com Deutsch | ||
21.08. | MEDICURE INC - 6-K, Report of foreign issuer | - | SEC Filings | ||
20.08. | Medicure, Inc.: Medicure Reports Financial Results for Quarter Ended June 30, 2025 | 417 | ACCESS Newswire | WINNIPEG, MB / ACCESS Newswire / August 20, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC:MCUJF), a company focused on the development and commercialization of pharmaceuticals and... ► Artikel lesen | |
19.08. | Medicure Inc (2): Medicure to release Q2 results Aug. 20 | 1 | Stockwatch | ||
18.08. | Medicure, Inc.: Medicure to Present Financial Results on August 21, 2025 Call at 8:30 am ET for Quarter Ended June 30, 2025 | 319 | ACCESS Newswire | WINNIPEG, MB / ACCESS Newswire / August 18, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC:MCUJF), a company focused on the development and commercialization of pharmaceuticals and... ► Artikel lesen | |
18.06. | Medicure Inc (2): Medicure closes acquisition of West Olympia Pharmacy | 1 | Stockwatch | ||
MEDICURE Aktie jetzt für 0€ handeln | |||||
18.06. | MEDICURE INC - 6-K, Report of foreign issuer | - | SEC Filings | ||
17.06. | Medicure, Inc.: Medicure Announces Closing of Purchase Agreement for The Acquisition of West Olympia Pharmacy | 850 | ACCESS Newswire | WINNIPEG, MB / ACCESS Newswire / June 17, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals... ► Artikel lesen | |
21.05. | Medicure, Inc.: Medicure Reports Financial Results for Quarter Ended March 31, 2025 and Annual General Meeting Director Election Results | 526 | ACCESS Newswire | WINNIPEG, MB / ACCESS Newswire / May 21, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC Pink:MCUJF), a company focused on the development and commercialization of pharmaceuticals... ► Artikel lesen | |
21.05. | MEDICURE INC - 6-K, Report of foreign issuer | 4 | SEC Filings | ||
28.04. | Medicure reports FY results | 8 | Seeking Alpha | ||
25.04. | MEDICURE INC - 20-F, Annual and transition report of foreign private issuers | 3 | SEC Filings | ||
23.04. | Medicure Inc (2): Medicure to release 2024 results April 29 | 5 | Stockwatch | ||
23.04. | Medicure, Inc.: Medicure to Present Financial Results on April 29, 2025 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2024 | 374 | ACCESS Newswire | WINNIPEG, MB / ACCESS Newswire / April 22, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals... ► Artikel lesen | |
11.04. | Medicure, Inc.: Medicure Announces Further Expansion of Its Pharmacy Business Through Signing of a Purchase Agreement for the Acquisition of West Olympia Pharmacy | 338 | ACCESS Newswire | WINNIPEG, MB / ACCESS Newswire / April 11, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals... ► Artikel lesen | |
12.03. | Medicure, Inc.: Medicure Announces Closing of Purchase Agreement for the Acquisition of Gateway Medical Pharmacy | 494 | ACCESS Newswire | WINNIPEG, MB / ACCESS Newswire / March 11, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals... ► Artikel lesen | |
18.02. | Medicure, Inc.: Medicure Announces Expansion of Its Pharmacy Business Through Signing of a Purchase Agreement for the Acquisition of Gateway Medical Pharmacy | 293 | ACCESS Newswire | WINNIPEG, MB / ACCESS Newswire / February 18, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC:MCUJF), a company focused on the development and commercialization of pharmaceuticals... ► Artikel lesen | |
26.11.24 | Medicure, Inc.: Medicure Reports Financial Results For Quarter Ended September 30, 2024 | 467 | ACCESS Newswire | WINNIPEG, MB / ACCESSWIRE / November 25, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals... ► Artikel lesen | |
18.11.24 | Medicure, Inc.: Medicure to Present Financial Results on November 26, 2024 Call at 8:30 AM ET for Quarter Ended September 30, 2024 and Announces Resignation of Board Member | 408 | ACCESS Newswire | WINNIPEG, MB / ACCESSWIRE / November 18, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
NOVO NORDISK | 49,770 | -0,15 % | Pharma unter Druck: Schlankheitskur bei Novo Nordisk: Der Jobabbau trifft die US-Produktion hart | © Foto: Blondet Eliot/ABACA - abacaNovo Nordisk baut in den USA Stellen ab, obwohl das Werk erweitert wird. Der Konzern will Kosten senken und effizienter werden. Anleger reagieren positiv.Novo Nordisk... ► Artikel lesen | |
PFIZER | 21,375 | +0,02 % | Wo noch Wachstum stattfindet - PanGenomic Health, Redcare Pharmacy, Pfizer | Die deutsche Industrie meldete zum wiederholten Male weniger Aufträge. Zum vierten Mal in Folge setzte sich der Negativtrend fort und im August fielen die Neuaufträge um 0,8 % unterhalb des Vormonats... ► Artikel lesen | |
GILEAD SCIENCES | 102,48 | +0,25 % | Gilead Sciences, Inc.: Gilead and Kite Reinforce Bold Commitment to Transform Cancer Care With New Data at ESMO 2025 | Late-breaking Phase 3 ASCENT-03 Study Results Highlight Potential for Trodelvy to Redefine First-Line Metastatic Triple-Negative Breast Cancer Treatment New EDGE-Gastric Overall Survival Results... ► Artikel lesen | |
AURORA CANNABIS | 4,670 | -0,74 % | Piramal Pharma Solutions Implements POD Method at Aurora API Facility | ||
GSK | 18,810 | +0,59 % | GSK stellt auf dem Gartner Supply Chain Planning Summit seine beschleunigte IBP-Transformation mit OMP vor | ANTWERPEN, BE / ACCESS Newswire /
9. Oktober 2025 / OMP, ein führender Anbieter von Lösungen für die Lieferkettenplanung, stellt auf dem Gartner Supply Chain Planning Summit 2025 in London vor... ► Artikel lesen | |
ABBVIE | 199,40 | +0,10 % | Abbvie - ABBV: Berenberg-Bank JETZT mit "KAUFEN"! | Kursziel 270 USD! Skyrizi & Rinvoq lösen Humira als Umsatzbringer für Abbvie ab! Marktführer bei Immunologie! Abbvie (ABBV) - ISIN US00287Y1091 Rückblick: Mit einem Kursplus von rund 30 Prozent beeindruckte... ► Artikel lesen | |
CANOPY GROWTH | 1,216 | +2,36 % | Canopy Growth Corp (2): Canopy's DOJA facility now a medical cultivation site | ||
ELI LILLY | 707,80 | -0,04 % | Eli Lilly: Die Bullen scheinen zurück - Trendwende geglückt? | Trendbetrachtung auf Basis 6 Monate: Die letzten Monate hatten es in sich. Nach einem beachtlichen Höhenflug zu Jahresbeginn kam es bei der Aktie des US-amerikanischen Pharmaunternehmens zu einer deutlichen... ► Artikel lesen | |
TILRAY BRANDS | 1,466 | -0,54 % | Zweistellig gestiegen: Tilray high: Nach den Ergebnissen knallt die Aktie! | © Foto: Dall-ENach einer langen Verlustserie macht Tilray Gewinne. Das gefällt auch den Anlegern. Die Aktie klettert zweistellig.Tilray liefert im ersten Quartal des Geschäftsjahres 2026 ein echtes... ► Artikel lesen | |
BRISTOL-MYERS SQUIBB | 37,640 | -0,05 % | Nach Novo Nordisk: Jetzt schlägt auch Bristol Myers Squibb zu | Das Übernahmekarussell im Biotechnologie-Sektor dreht sich dynamisch weiter. Nachdem Novo Nordisk die milliardenschwere Übernahme des AKTIONÄR-Tipps Akero am Donnerstag bekanntgegeben hat, kann auch... ► Artikel lesen | |
TEVA | 17,350 | 0,00 % | Teva: FDA Grants Expanded Approval For UZEDY To Treat Bipolar I Disorder In Adults | PETAH TIKVA (dpa-AFX) - Teva Pharmaceuticals, the U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), in collaboration with Medincell (MEDCL.PA), announced that the U.S. Food and Drug... ► Artikel lesen | |
VERTEX PHARMACEUTICALS | 352,55 | +0,09 % | Gilead's Yeztugo, Eisai's Leqembi Iqlik, Vertex's Journavx among 2025's best inventions: Time | ||
ABBOTT LABORATORIES | 113,50 | -0,09 % | Abbott is a steady Medtech company in an unsteady world, says Benchmark | ||
TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | CSE Bulletin: Suspensions - Blender Bites Limited, TAAT Global Alternatives Inc. | Toronto, Ontario--(Newsfile Corp. - Le 16 mai/May 2025) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as... ► Artikel lesen | |
MPH HEALTH CARE | 18,050 | +1,40 % | Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH): Kaufen | Original-Research: MPH Health Care AG - from First Berlin Equity Research GmbH
18.09.2025 / 16:25 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer... ► Artikel lesen |